A potential pitfall in the use of the Disease Activity Score (DAS28) as the main response criterion in treatment guidelines for patients with rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 64, Issue 3, 2005, Pages 506-507

  Gardiner, P V ^a   Bell, A L ^b   Taggart, A J ^b   Wright, G ^b   Kee, F ^c   Smyth, A ^d   McKane, R ^d   Lee, J ^e   Rooney, M E ^b   Whitehead, E ^f  

^a ALTNAGELVIN HOSPITAL   (United Kingdom)

^b MUSGRAVE PARK HOSPITAL   (United Kingdom)

^c NORTHERN HEALTH AND SOCIAL CARE TRUST   (United Kingdom)

^d ULSTER HOSPITAL   (United Kingdom)

^e CRAIGAVON AREA HOSPITAL   (United Kingdom)

^f ANTRIM AREA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCULATION; CASE REPORT; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE 28; DISEASE CLASSIFICATION; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 20044394007     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.025015     Document Type: Article

References (2)

1. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
2. BSR. Guidelines for prescribing TNF-α blockers in adults with rheumatoid arthritis. Report of a working party of the British Society for Rheumatology. London: BSR, 2001.